Compare Quest Diagnostics Inc (DGX) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Star Bulk Carriers Corp — how do they compare? Quest Diagnostics Inc trades at $230.78 (market cap $25.48B), while Star Bulk Carriers Corp trades at $29.91 (market cap $3.54B). The key difference: Quest Diagnostics Inc is far larger — about 7.2× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays the higher dividend (6.17%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Star Bulk Carriers Corp for 24 Days on average.
| DGX | SBLK | |
|---|---|---|
Market Cap | $25.48B | $3.54B |
Volume | 941,866 | 1,437,622 |
Sector | Health | Industrials |
52-Week High | $247.45 | $32.49 |
52-Week Low | $173.49 | $16.79 |
Typical Hold Time | 56 Days | 24 Days |
Enterprise Value | $31.23B | $4.22B |
Dividend Yield | 1.49% | 6.17% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.76, up 1.66% today, reflecting strong year-to-date momentum driven by consistent earnings beats and growth in advanced diagnostics. The stock is near its 52-week high with a consensus price target of $250, indicating further upside potential. Recent news highlights partnerships, such as integration with Apple Health, and clinical study successes, though Medicare reimbursement cuts pose a headwind. Technical indicators show a bearish signal overall, with support at $228 and resistance at $232.
The outlook remains positive due to robust revenue growth, expanding profit margins, and strategic initiatives, but risks include regulatory pressure on lab payments and rising debt levels. Analyst sentiment is mixed, with a majority holding neutral ratings, suggesting cautious optimism amid execution challenges and market volatility.
Star Bulk Carriers (SBLK) trades at $29.86, up 0.57% today, with a bullish technical signal from moving averages and a neutral RSI. The company demonstrates strong fundamentals, with Q2 2026 EPS of $1.21 beating expectations and a net income margin of 23.87%. Recent news highlights insider buying and a declared $0.90 dividend, reflecting confidence in the shipping sector's momentum.
The outlook for SBLK is positive, supported by robust earnings growth, attractive valuation metrics like a P/E of 11.95, and a high analyst buy consensus of 58.34%. Key risks include exposure to volatile shipping rates and macroeconomic pressures, but the company's solid cash flow and dividend policy offer shareholder value. Upside potential hinges on continued operational execution and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
